Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy
(99)
Mirone, Vincenzo
a
Imbimbo, Ciro
a
Rossi, Andrea
b
Sicuteri, Riccardo
b
Valle, Domenico
b
Longo, Nicola
c
Fusco, Ferdinando
a
Alei, G
c
Anselmo, G
c
Aquilini, M
c
Bellorofonte, C
c
Bonno, A
c
Boscaro, M
c
Bozzo, W
c
Breda, G
c
Caotorta, M M
c
Carani, C
c
Casarico, A
c
Cassutti, V
c
Cecchi, M
c
Cicalese, V
c
Comeri, G
c
Cordari, M
c
Cormio, L
c
D'Agata, G
c
D'Alia, O
c
De Dominicis, C
c
De Grande, G
c
Di Mario, U
c
Di Rienzo, A
c
Fasolis, G
c
Fasolo, C B
c
Fedele, D
c
Ferrara, V
c
Foresta, C
c
Forti, G
c
Francavilla, S
c
Frea, B
c
Genovese, S
c
Gentile, V
c
Ghigo, E
c
Giampietro, O
c
Imbimbo, C
c
Jacobellis, U
c
Jandolo, B
c
Jannini, E
c
La Pera, G
c
Lembo, A
c
Lenzi, A
c
Ludovico, G
c
Macchia, E
c
Maffucci, A
c
Maio, G
c
Malossini, G
c
Mantero, F
c
Marin, A
c
Mazza, G
c
Mazzarella, F
c
Menchini Fabris, F
c
Montorsi, F
c
Muzzonigro, G
c
Nasta, A
c
Nicita, G
c
Nobile, C
c
Pagano, A
c
Paolini, R
c
Paradiso, M
c
Pavone, C
c
Pescatori, E
c
Pittaluga, P
c
Poletti, F
c
Pontiroli, A
c
Porena, M
c
Provenzano, C
c
Pycha, A
c
Ranno, S
c
Ruggeri, M
c
Scarano, P
c
Scarpa, R M
c
Scionti, L
c
Selli, C
c
Serao, A
c
Sidari, V
c
Sorrentino, F
c
Spera, E
c
Spera, G
c
Strada, G
c
Tasca, A
c
Tatti, P
c
Toscano, V
c
Trevisan, R
c
Trinchera, A
c
Turchi, P
c
Usai, E
c
Vecchio, D
c
Ventrice, G A
c
Vita, A
c
Volpi, R
c
Zenico, T
c
more..
|
-
1
-
-
0038353576
-
Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial
-
Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial. Urology 2003; 62: 121-5.
-
(2003)
Urology
, vol.62
, pp. 121-125
-
-
Porst, H.1
Padma-Nathan, H.2
Giuliano, F.3
Anglin, G.4
Varanese, L.5
Rosen, R.6
-
2
-
-
0036197133
-
IC351 (tadalafil, Cialis): Update on clinical experience
-
Porst H. IC351 (tadalafil, Cialis): Update on clinical experience. Int J Impot Res 2002; 14 (Suppl 1): S57-64.
-
(2002)
Int J Impot Res
, vol.14
, Issue.SUPPL. 1
-
-
Porst, H.1
-
3
-
-
21144476846
-
An evaluation of an alternative dosing regimen with tadalafil, 3 times/ week, for men with erectile dysfunction: SURE study in 14 European countries
-
Mirone V, Costa P, Damber JE, Holmes S, Moncada I, Van Ahlen H, et al. An evaluation of an alternative dosing regimen with tadalafil, 3 times/ week, for men with erectile dysfunction: SURE study in 14 European countries. Eur Urol 2005; 47: 846-54.
-
(2005)
Eur Urol
, vol.47
, pp. 846-854
-
-
Mirone, V.1
Costa, P.2
Damber, J.E.3
Holmes, S.4
Moncada, I.5
Van Ahlen, H.6
-
4
-
-
0036783940
-
Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses
-
Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses. J Urol 2002; 168: 1332-6.
-
(2002)
J Urol
, vol.168
, pp. 1332-1336
-
-
Brock, G.B.1
McMahon, C.G.2
Chen, K.K.3
Costigan, T.4
Shen, W.5
Watkins, V.6
-
5
-
-
0036868441
-
Vardenafil for treatment of men with erectile dysfunction: Efficacy and safety in a randomized, double-blind, placebo-controlled trial
-
Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 2002; 23: 763-71.
-
(2002)
J Androl
, vol.23
, pp. 763-771
-
-
Hellstrom, W.J.1
Gittelman, M.2
Karlin, G.3
Segerson, T.4
Thibonnier, M.5
Taylor, T.6
-
6
-
-
0032516296
-
Oral sildenafil in the treatment of erectile dysfunction
-
Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338: 1397-404.
-
(1998)
N Engl J Med
, vol.338
, pp. 1397-1404
-
-
Goldstein, I.1
Lue, T.F.2
Padma-Nathan, H.3
Rosen, R.C.4
Steers, W.D.5
Wicker, P.A.6
-
7
-
-
27644499337
-
Treatment for erectile dysfunction based on patient-reported outcomes: To every man the PDE5 inhibitor that he finds superior
-
Hedelin H, Stroberg P. Treatment for erectile dysfunction based on patient-reported outcomes: To every man the PDE5 inhibitor that he finds superior. Drugs 2005; 65: 2245-51.
-
(2005)
Drugs
, vol.65
, pp. 2245-2251
-
-
Hedelin, H.1
Stroberg, P.2
-
8
-
-
0036589997
-
Patient choice is critical in managing erectile dysfunction
-
Heaton JP, Hackett G, Savage D, Padley RJ. Patient choice is critical in managing erectile dysfunction. Eur Urol 2002; 1 (Suppl 1): 33-7.
-
(2002)
Eur Urol
, vol.1
, Issue.SUPPL. 1
, pp. 33-37
-
-
Heaton, J.P.1
Hackett, G.2
Savage, D.3
Padley, R.J.4
-
9
-
-
29044448811
-
Evaluating preference trials of oral phosphodiesterase 5 inhibitors for erectile dysfunction
-
Mulhall JP, Montorsi F. Evaluating preference trials of oral phosphodiesterase 5 inhibitors for erectile dysfunction. Eur Urol 2006; 49: 30-7.
-
(2006)
Eur Urol
, vol.49
, pp. 30-37
-
-
Mulhall, J.P.1
Montorsi, F.2
-
10
-
-
31144472113
-
Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors
-
Sommer F, Schulze W. Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors. World J Urol 2005; 23: 385-92.
-
(2005)
World J Urol
, vol.23
, pp. 385-392
-
-
Sommer, F.1
Schulze, W.2
|